IP Verse

Glaxosmithkline Biologicals S.a. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Glaxosmithkline Biologicals S.a.

Patent Number:
EP2558116
Title:
Agent For Locally Treating Cervical Dysplasias
Applicant:
CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN
Opposition Date:
Dec 21, 2017

Latest patents of Glaxosmithkline Biologicals S.a. opposed by its competitors

Patent:
EP4043040
Grant Date:
Jan 11, 2023
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
4
Patent:
EP4008357
Grant Date:
Dec 28, 2022
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
4
Patent:
EP4066855
Grant Date:
Dec 28, 2022
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
4
Patent:
EP4066857
Grant Date:
Dec 21, 2022
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
4
Patent:
EP4066856
Grant Date:
Dec 7, 2022
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
4
Patent:
EP4005592
Grant Date:
Oct 12, 2022
Title:
Virion-Like Delivery Particles For Self-Replicating Rna Molecules
Oppositions:
2
Patent:
EP3981427
Grant Date:
Jul 27, 2022
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
5
Patent:
EP3970742
Grant Date:
May 25, 2022
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Oppositions:
5
Patent:
EP3178490
Grant Date:
Apr 20, 2022
Title:
Rsv F Protein Compositions And Methods For Making Same
Oppositions:
2
Patent:
EP3482770
Grant Date:
Nov 25, 2020
Title:
Immunogenic Compositions
Oppositions:
1

Competitors of Glaxosmithkline Biologicals S.a.

JG OPPOSITIONS LIMITED

SANOFI

THOMANN, WILLIAM

Want to track Glaxosmithkline Biologicals S.a.?

Feel free to send us a message here and we will get back to you